Search

Second EHA-SAH tutorial in Argentina, another success

Hematologists from South America and mainland US gathered in Argentina on September 14-15 for brain-stretching exercises on the topics of lymphoid malignancies and plasma cell dyscrasias.

Read more

A Special Coach for the Cantera 2024

A unique tutorial for young hematologists, co-sponsored by the EHA Lymphoma Group and the Fondazione Italiana Linfomi. DatesMay 14 to May 17, 2024. LocationLecce, Italy. TopicHow the utilization of cellular therapy strategies looks for lymphomas in 2024.

Read more

Horizon 2020: The European Commission proposes the successor to Framework Programme 7

Horizons 2020 will pay “particular attention to ensuring a broad approach to innovation, which is not only limited to the development of new products and services on the basis of scientific and technological breakthroughs, but which also incorporates aspects such…

Read more

Overview of EHA's Hemoglobinopathies Initiatives

The EHA Topics-in-Focus Hemoglobinopathies Program  (focus on Sickle Cell Disease) aims to expand awareness and education about these increasingly common genetic diseases in Europe, among healthcare professionals, patients and the general population.

Read more

Join EHA and BSH and receive a discount on your EHA membership fee!

We are pleased to inform that EHA and the British Society of Haematology (BSH) have joined forces and are offering you the possibility of an EHA-BSH Joint Membership.

Read more

Registration

Register for the on-demand recordings

Individual registration
The virtual registration includes:

On-demand access to the recordings of the scientific and educational sessions of the meeting that took place 10-12 November, 2022.

Read more

Faculty Information

We are honored that you have agreed to be a part of the faculty for the EHA-TSH Hematology Tutorial on T Cell Lymphomas, scheduled to be held on June 29-30, 2024 in Ankara, Türkiye.

Read more

Adolescents and young adults (AYA)

Spotlight on AYAAdolescents and young adults (AYA) with hematologic diseases are a unique group with special characteristics and needs. In recent years, the challenges related to the management of AYA (particularly in relation to cancer) have increasingly been recognized.

Read more